BioSpace News Archive

Seizure Detection Device Market Size 2022 to 2030 – Quantitative Research by QYResearch Medical

Seizure is a medical condition in which the normal nerve cell activities in the brain is disturbed.

September 12, 2022
·
4 min read
BioForest

Alpine Immune Sciences to Highlight Clinical Updates on Autoimmune and Immuno-Oncology Programs at Inaugural R&D Day

Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune and inflammatory diseases, today announced clinical updates from two wholly owned programs, ALPN-303 and davoceticept.

September 12, 2022
·
10 min read
Entera Bio to Present at H.C. Wainwright 24th Annual Global Investment Conference

Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, today announced that the Company will present and host 1x1 meetings at the upcoming H.C. Wainwright 24th Annual Global Investment Conference.

September 12, 2022
·
1 min read
Pharm Country

Celsion Corporation Presentation Time at the H.C. Wainwright 24th Annual Global Investment Conference Changed to 4:30 p.m. ET on September 13

Celsion Corporation (NASDAQ: CLSN), a clinical-stage drug development company, announces that Dr. Corinne Le Goff, President and Chief Executive Officer, will present a company overview at the H.C. Wainwright 24th Annual Global Investment Conference on September 13th at 4:30 p.m. Eastern time.

September 12, 2022
·
1 min read
Business

Advaxis Reports Third Quarter Ended July 31, 2022 Financial Results and Provides a Business Update

Advaxis, Inc. (OTCQX: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today announces its financial results for the third quarter ended July 31, 2022 and provides a business update.

September 12, 2022
·
6 min read
Biotech Bay

Benitec Biopharma Inc. Announces Pricing of $18 Million Underwritten Public Offering - September 13, 2022

Benitec Biopharma Inc. announced the pricing of its underwritten public offering of 29,809,471 shares of its common stock and accompanying warrants to purchase up to 29,809,471 shares of common stock.

September 12, 2022
·
4 min read
Genetown

Relay Therapeutics Announces Pricing of Public Offering of Common Stock - September 13, 2022

Relay Therapeutics, Inc. announced the pricing of an underwritten public offering of 11,320,755 shares of its common stock at a public offering price of $26.50 per share.

September 12, 2022
·
4 min read
Next Generation Antibody Therapeutics Market Share and Growth Factors Impact Analysis 2019 – 2027

As the name suggests, next-generation antibody therapeutics is characteristic of advanced antibody therapeutics.

September 12, 2022
·
5 min read
Terahertz Spectroscopy Market Analysis of the Competitive Landscape, with a Forecast for 2026

The outbreak of novel coronavirus in 2020 has created a massively increased demand for precise treatment and diagnostic devices in the global healthcare industries.

September 12, 2022
·
7 min read
Bone Growth Stimulators Market Size to Hit USD 3.8 Billion by 2030

According to Nova one advisor, the global Bone Growth Stimulators market was valued at USD 1.95 billion in 2021 and it is expected to hit around USD 3.8 billion by 2030 with a CAGR of 7.69% during the forecast period 2022 to 2030.

September 12, 2022
·
11 min read